Clinical Trials Directory

Trials / Completed

CompletedNCT00593671

Preimplantation Genetic Screening in Women Over 35 Year

Preimplantation Genetic Screening for Aneuploidy in Embryos After in Vitro Fertilization in Women Over 35: a Prospective Controlled Randomized Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
35 Years – 45 Years
Healthy volunteers
Accepted

Summary

In view of insufficient evidence to routinely use Preimplantation Genetic Screening (PGS) to improve success rates after IVF, we test the hypothesis that patients with advanced maternal age (AMA) have a higher implantation rate (IR) after embryo transfer (ET) of chromosomally normal embryos following PGS compared to patients who had an ET without PGS. In a randomized controlled trial (RCT) in patients with AMA (≥ 35 years), the clinical IR per embryo transferred will be compared after ET on day 5 or 6 between the PGS group (embryo biopsy and analysis of chromosomes 13, 16, 18, 21, 22, X and Y) and the control group without PGS.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreimplantation genetic screening after embryo biopsyPreimplantation genetic screening after embryo biopsy

Timeline

Start date
2002-06-01
Primary completion
2007-01-01
Completion
2007-01-01
First posted
2008-01-15
Last updated
2008-01-15

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00593671. Inclusion in this directory is not an endorsement.

Preimplantation Genetic Screening in Women Over 35 Year (NCT00593671) · Clinical Trials Directory